[Cephalexin monohydrate in pediatrics. Clinical, bacteriological experiences and the hematic, hepatic and renal tolerance in 120 children with respiratory infections].
D000293:Adolescent; D001773:Blood Cells / Q000187:drug effects*; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007668:Kidney / Q000187:drug effects*; D007710:Klebsiella Infections / Q000188:drug therapy; D007818:Laryngeal Diseases / Q000188:drug therapy; D008099:Liver / Q000187:drug effects*; D008297:Male; D010612:Pharyngitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D002511:Cephalosporins
Monohidrato de cefalexina en pediatría. Experiencia clínica, bacteriológica y de tolerancia hemática, hepática y renal en 120 niños con infecciones respiratorias.